<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="rmv70069" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Med Virol</journal-id><journal-id journal-id-type="iso-abbrev">Rev Med Virol</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">RMV</journal-id><journal-title-group><journal-title>Reviews in Medical Virology</journal-title></journal-title-group><issn pub-type="ppub">1052-9276</issn><issn pub-type="epub">1099-1654</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12431719</article-id><article-id pub-id-type="pmcid-ver">PMC12431719.1</article-id><article-id pub-id-type="pmcaid">12431719</article-id><article-id pub-id-type="pmcaiid">12431719</article-id><article-id pub-id-type="pmid">40939094</article-id><article-id pub-id-type="doi">10.1002/rmv.70069</article-id><article-id pub-id-type="publisher-id">RMV70069</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>The Cerebral Haemorrhage and SARS&#8208;CoV&#8208;2: An Emerging Virus From a Meta&#8208;Analysis Perspective</article-title></title-group><contrib-group><contrib id="rmv70069-cr-0001" contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Y">Yuxia</given-names></name><xref rid="rmv70069-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="rmv70069-cr-0002" contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="C">Chao</given-names></name><xref rid="rmv70069-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="rmv70069-cr-0003" contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="Y">Yunzhu</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0009-3326-1091</contrib-id><xref rid="rmv70069-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><address><email>zyz4123@126.com</email></address></contrib><contrib id="rmv70069-cr-0004" contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="Z">Zhuwei</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-1911-3312</contrib-id><xref rid="rmv70069-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>bt465746@gmail.com</email></address></contrib></contrib-group><aff content-type="private-address" id="rmv70069-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>Geriatric Medicine Center, Department of Endocrinology</institution>
<institution>Zhejiang Provincial People's Hospital</institution>
<institution>Affiliated People's Hospital</institution>
<institution>Hangzhou Medical College</institution>
<city>Hangzhou</city>
<named-content content-type="country-part">Zhejiang</named-content>
<country country="CN">China</country>
</aff><aff id="rmv70069-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Neurosurgery</named-content>
<institution>Linyi City People's Hospital</institution>
<city>Linyi</city>
<country country="CN">China</country>
</aff><aff id="rmv70069-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Nursing</named-content>
<institution>Linyi Central Hospital</institution>
<city>Linyi</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence:</bold> Yunzhu Zhang<break/>
(<email>zyz4123@126.com</email>) and<break/>
Zhuwei Zhang<break/>
(<email>bt465746@gmail.com</email>)<break/></corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2025</year></pub-date><volume>35</volume><issue seq="20">5</issue><issue-id pub-id-type="pmc-issue-id">496736</issue-id><issue-id pub-id-type="doi">10.1002/rmv.v35.5</issue-id><elocation-id>e70069</elocation-id><history><date date-type="rev-recd"><day>11</day><month>8</month><year>2025</year></date><date date-type="received"><day>28</day><month>7</month><year>2025</year></date><date date-type="accepted"><day>18</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">Reviews in Medical Virology</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="RMV-35-e70069.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:RMV-35-e70069.pdf"/><abstract><title>ABSTRACT</title><p>The central nervous system is a potential target of the COVID&#8208;19 virus, and one of the devastating neurological consequences of this infection is cerebral haemorrhage (ICH). Cerebral haemorrhage is a leading cause of death worldwide. This study aimed to systematically review and analyse the existing literature on this topic and provide insights into the potential neurological consequences of COVID&#8208;19. A comprehensive search was conducted across the PubMed, Scopus, Web of Science, and Embase databases to extract relevant published data up to February 2025. This meta&#8208;analysis included 11 studies involving a total of 197,060 individuals. Subgroup analyses were performed based on the year of publication, hospital sampling wards, and study design. A critical appraisal was carried out using the Newcastle&#8211;Ottawa Scale (NOS) score. Risk was utilised as a measure of pooled effect size based on a random&#8208;effects model. In this analysis, we identified 11 articles that directly assessed the risk of cerebral haemorrhage. The reported risk of cerebral haemorrhage was five cases per 10,000 COVID&#8208;19 patients [0.005 (95% CI: 0.002&#8211;0.009), <italic toggle="yes">p</italic>&#160;&lt;&#160;0.001]. Notably, studies published in 2022 and 2023 indicated a significantly higher risk of cerebral haemorrhage compared to earlier years. COVID&#8208;19 patients admitted to the intensive care unit (ICU) faced an increased risk of cerebral haemorrhage compared to those admitted to general wards. Meta&#8208;regression analysis revealed a statistically significant association between the risk of cerebral haemorrhage and the type of wards in a hospital [0.0089 (95% CI: 0.0067&#8211;0.0112), <italic toggle="yes">p</italic>&#160;&lt;&#160;0.001], as well as the year of publication [0.0004 (95% CI: 0.0003&#8211;0.0008), <italic toggle="yes">p</italic>&#160;=&#160;0.048]. Therefore, it is essential to evaluate COVID&#8208;19 patients admitted to the ICU in recent years for the potential occurrence of cerebral haemorrhage.</p></abstract><kwd-group><kwd id="rmv70069-kwd-0001">cerebral haemorrhage</kwd><kwd id="rmv70069-kwd-0002">emerging virus</kwd><kwd id="rmv70069-kwd-0003">meta&#8208;analysis</kwd><kwd id="rmv70069-kwd-0004">SARS&#8208;CoV&#8208;2</kwd></kwd-group><counts><fig-count count="4"/><table-count count="3"/><page-count count="10"/><word-count count="4540"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.2 mode:remove_FC converted:12.09.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="self-citation" id="rmv70069-cit-0032"><string-name name-style="western"><given-names>Wang</given-names><surname>Yuxia</surname></string-name>, <string-name name-style="western"><given-names>Chao</given-names><surname>Zhang</surname></string-name>, <string-name name-style="western"><given-names>Yunzhu</given-names><surname>Zhang</surname></string-name>, and <string-name name-style="western"><given-names>Zhuwei</given-names><surname>Zhang</surname></string-name>. <year>2025</year>. <article-title>&#8220;The Cerebral Haemorrhage and SARS&#8208;CoV&#8208;2: An Emerging Virus From a Meta&#8208;Analysis Perspective.&#8221;</article-title><source>Reviews in Medical Virology</source>: <elocation-id>e70069</elocation-id>. <pub-id pub-id-type="doi">10.1002/rmv.70069</pub-id>.<pub-id pub-id-type="pmid">40939094</pub-id><pub-id pub-id-type="pmcid">PMC12431719</pub-id></mixed-citation>
</p><fn-group><fn fn-type="equal" id="rmv70069-note-0001"><p>The first two authors equally contributed to this work.</p></fn></fn-group></notes></front><body id="rmv70069-body-0001"><sec id="rmv70069-sec-0010"><label>1</label><title>Introduction</title><p>COVID&#8208;19 infections primarily affect the respiratory system, leading to viral pneumonia through the binding of the SARS&#8208;CoV&#8208;2 spike protein to the endothelial angiotensin converting enzyme&#8208;2 (ACE&#8208;2) receptor [<xref rid="rmv70069-bib-0001" ref-type="bibr">1</xref>]. Increasing evidence indicates that SARS&#8208;CoV&#8208;2 is not solely confined to the respiratory system; it can also affect the cardiovascular, digestive, renal, nervous, and reproductive systems [<xref rid="rmv70069-bib-0002" ref-type="bibr">2</xref>, <xref rid="rmv70069-bib-0003" ref-type="bibr">3</xref>, <xref rid="rmv70069-bib-0004" ref-type="bibr">4</xref>]. The central nervous system (CNS) is one potential target of the COVID&#8208;19 virus, and devastating neurologic consequences of infections were reported early in the pandemic [<xref rid="rmv70069-bib-0005" ref-type="bibr">5</xref>]. One specific pathology that can lead to these severe neurological outcomes is cerebral haemorrhage. There has been a higher incidence of cerebral haemorrhage associated with COVID&#8208;19 compared to other respiratory viruses, such as the influenza virus [<xref rid="rmv70069-bib-0006" ref-type="bibr">6</xref>].</p><p>The mechanisms of neurovascular injury in COVID&#8208;19 are multifactorial. Damage to vascular endothelial cells, along with subsequent harm to the vasculature, increases the risk of both ischaemic and haemorrhagic events [<xref rid="rmv70069-bib-0007" ref-type="bibr">7</xref>, <xref rid="rmv70069-bib-0008" ref-type="bibr">8</xref>]. Cerebral haemorrhage (ICH), a condition characterised by bleeding within the brain, is a leading cause of morbidity and mortality worldwide. Traditionally associated with conditions such as hypertension, trauma, and aneurysms, recent evidence has highlighted an emerging and concerning relationship between cerebral haemorrhage and SARS&#8208;CoV&#8208;2. Growing clinical observations suggest that COVID&#8208;19 infection may predispose individuals to a range of neurological complications, including stroke, encephalopathy, and, notably, particularly cerebral haemorrhage. The underlying mechanisms of these associations remain complex, potentially involving SARS&#8208;CoV&#8208;2&#8208;induced inflammation, coagulopathy, and direct neurovascular damage [<xref rid="rmv70069-bib-0009" ref-type="bibr">9</xref>, <xref rid="rmv70069-bib-0010" ref-type="bibr">10</xref>].</p><p>In light of these findings, a meta&#8208;analytic approach is increasingly being employed to consolidate data from multiple studies, enhancing our understanding of the prevalence, risk factors, and potential pathophysiological mechanisms linking SARS&#8208;CoV&#8208;2 to cerebral haemorrhage. This article aims to systematically review and analyse the existing literature on this topic, providing insights into the potential neurological consequences of COVID&#8208;19 and identifying gaps for further research to inform clinical practice and public health strategies.</p></sec><sec id="rmv70069-sec-0020"><label>2</label><title>Methods</title><sec id="rmv70069-sec-0030"><label>2.1</label><title>Literature Search Strategy</title><p>The PRISMA statement was followed in conducting this meta&#8208;analysis [<xref rid="rmv70069-bib-0011" ref-type="bibr">11</xref>]. We performed a comprehensive literature search using the online databases PubMed, Scopus, Web of Science, and Embase, covering publications up to February 2025. The search terms included &#8216;Cerebral Haemorrhage OR Intracerebral Haemorrhage OR Cerebrum Haemorrhage OR Cerebral Brain Haemorrhage OR Cerebral Parenchymal Haemorrhage&#8217; and &#8216;severe acute respiratory syndrome OR SARS Coronavirus&#8208;2 OR SARS OR SARS CoV OR 2019&#8208;novel coronavirus OR Coronavirus nCoV OR 2019&#8208;nCoV OR COVID OR SARS&#8208;CoV&#8208;2 OR COVID&#8208;19 OR COVID&#8208;19 Virus OR COVID&#8208;19 Pandemic were Pandemic,&#8217; which the used to identify literature.</p></sec><sec id="rmv70069-sec-0040"><label>2.2</label><title>Inclusion and Exclusion Criteria</title><p>Studies were included for further evaluation if they met the following criteria: (1) publications in English; (2) investigation of cerebral haemorrhage, including subarachnoid haemorrhage, intraparenchymal haemorrhage (IPH), subdural haemorrhage (SDH), or haemorrhage related to strokes and venous thrombosis; (3) determination of the association between cerebral haemorrhage and SARS&#8208;CoV&#8208;2 infection; and (4) evaluation of risk or incidence, along with their corresponding 95% confidence intervals (CIs), or sufficient data was provided to assess these associations. Studies were excluded based on the following criteria: non&#8208;English articles; other types of publications such as conference proceedings, abstracts, reviews, or meta&#8208;analyses; and insufficient data to calculate risk and 95% CIs.</p></sec><sec id="rmv70069-sec-0050"><label>2.3</label><title>Data Extraction and Quality Evaluation</title><p>All included studies were meticulously identified by two investigators, and any uncertain data were reviewed by a third author. The following information was collected: the first author's name, publication year, nationality, sample type, assay used to evaluate the expression of cerebral haemorrhage, sample size, type of cerebral haemorrhage, and the associated risk along with their 95% confidence intervals (CIs).</p><p>The quality assessment of the included studies was conducted using the Newcastle&#8208;Ottawa Scale (NOS) score, which evaluates the selection of study groups, the comparability of the groups, and the ascertainment of the outcome of interest for each study. Additionally, the quality assessment was performed by two independent researchers, and any disagreements were resolved by a third party. Overall, the results of the quality assessment indicate that the studies are of good quality.</p></sec><sec id="rmv70069-sec-0060"><label>2.4</label><title>Statistical Analysis</title><p>The association between SARS&#8208;CoV&#8208;2 infection and cerebral haemorrhage was evaluated using Stata software version 17, utilising a random effects model (StataCorp, 2024, Stata Statistical Software: Release 17, College Station, TX). The risk of cerebral haemorrhage and the corresponding 95% confidence intervals (CIs) were collected to evaluate the risk of cerebral haemorrhage in individuals infected with SARS&#8208;CoV&#8208;2.</p><p>Heterogeneity was assessed using the Q test and the I<sup>2</sup> index. Studies with an I<sup>2</sup> index of less than 25%, between 25% and 75%, and greater than 75% were categorised as having low, moderate, and high heterogeneity, respectively. In cases where the I<sup>2</sup> index exceeded 75%, a subgroup analysis was performed based on the year of publication of the article, the sampling wards in a hospital where the COVID&#8208;19 patients were admitted, and the method of diagnosis of cerebral haemorrhage.</p><p>Forest plots were utilised to visualise the risk in each study, along with the estimated values and their corresponding 95% confidence intervals (95% CI) in both the main analysis and the subgroup analysis. Publication bias of the meta&#8208;analysis was determined by Begg's test and Egger's test.</p></sec></sec><sec id="rmv70069-sec-0070"><label>3</label><title>Result</title><sec id="rmv70069-sec-0080"><label>3.1</label><title>Search Results</title><p>A total of 461 articles were retrieved from the databases PubMed, Scopus, Web of Science, and Embase during the initial search. We identified 175 papers from Medline/PubMed, 110 papers from Scopus, 115 papers from Web of Science, and 61 papers from Embase. After removing duplicates, case reports, case series, review articles, and meta&#8208;analyses, as well as studies that were not written in English or were unrelated, 63 records were deemed eligible for full&#8208;text review. Only 11 papers reported the risk of cerebral haemorrhage in patients with SARS&#8208;CoV&#8208;2. These 11 papers underwent quality assessment and were included in our meta&#8208;analysis (Figure&#160;<xref rid="rmv70069-fig-0001" ref-type="fig">1</xref>). The overall sample size comprised 197,060 patients, with individual studies ranging from 440 to 85,645 participants.</p><fig position="float" fig-type="FIGURE" id="rmv70069-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>PRISMA flowchart of study selection process. *Reason 1 = case reports, case series, and review articles. **Reason 2 = case&#8208;control and RCT articles.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="RMV-35-e70069-g004.jpg"/></fig></sec><sec id="rmv70069-sec-0090"><label>3.2</label><title>Main Characteristics</title><p>The eleven selected articles, which involve a sample size of 197,060 participants, have been published across four continents: America, Europe, Asia, and Oceania. The studies were published between 2020 and 2023. The individuals involved in the studies were people infected with COVID&#8208;19 who were referred to hospitals or other medical and research centres for treatment. Necessary tests were conducted to diagnose any brain and neurological damage. Table&#160;<xref rid="rmv70069-tbl-0001" ref-type="table">1</xref> presents a comprehensive overview of the key characteristics of the included studies. All articles were designed as cohort studies, incorporating both retrospective and prospective approaches. The primary distinction among them was the hospital departments from which the samples were collected: general and inpatient wards, and the intensive care unit (ICU). The lowest and highest risks of cerebral haemorrhage were 15 and 204 cases per 10,000 COVID&#8208;19 patients, respectively. In terms of methods for diagnosing cerebral haemorrhage, three studies utilised CT&#8208;scans, two studies employed MRI, and two studies used both MRI and CT&#8208;scans. Additionally, four studies did not clearly outline their diagnostic methods for cerebral haemorrhage and only referenced ICD&#8208;10 classification codes (unknown). We extracted data on COVID&#8208;19 diagnostic methods from all included studies. While the majority employed PCR&#8208;based confirmation, some relied on clinical or imaging criteria.</p><table-wrap position="float" id="rmv70069-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Baseline characteristics of the included studies in the systematic review and meta&#8208;analysis.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr><th rowspan="2" style="border-bottom:solid 1px #000000" align="left" valign="bottom" colspan="1">Authors</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">Year</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">Country</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">Study design</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">Sample size</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">No. ICH</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">Risk of ICH</th><th style="border-bottom:solid 1px #000000" colspan="2" align="center" valign="bottom" rowspan="1">95% CI</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">Sampling wards in a hospital</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">Diagnosis method of ICH</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">Diagnosis method of COVID&#8208;19</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">Lower</th><th align="center" valign="bottom" rowspan="1" colspan="1">Upper</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Le, et&#160;al. [<xref rid="rmv70069-bib-0025" ref-type="bibr">25</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2021</td><td align="center" valign="top" rowspan="1" colspan="1">USA, France, Brazil,&#160;Israel, Italy, and Russia</td><td align="center" valign="top" rowspan="1" colspan="1">Prospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">35,177</td><td align="center" valign="top" rowspan="1" colspan="1">71</td><td align="center" valign="top" rowspan="1" colspan="1">0.0020</td><td align="center" valign="top" rowspan="1" colspan="1">0.0015</td><td align="center" valign="top" rowspan="1" colspan="1">0.0025</td><td align="center" valign="top" rowspan="1" colspan="1">General wards</td><td align="center" valign="top" rowspan="1" colspan="1">Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">PCR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Shahjouei, et&#160;al. [<xref rid="rmv70069-bib-0026" ref-type="bibr">26</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2020</td><td align="center" valign="top" rowspan="1" colspan="1">America, Europe, Asia, and Oceania</td><td align="center" valign="top" rowspan="1" colspan="1">Retrospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">17,799</td><td align="center" valign="top" rowspan="1" colspan="1">27</td><td align="center" valign="top" rowspan="1" colspan="1">0.0015</td><td align="center" valign="top" rowspan="1" colspan="1">0.0009</td><td align="center" valign="top" rowspan="1" colspan="1">0.0022</td><td align="center" valign="top" rowspan="1" colspan="1">General wards</td><td align="center" valign="top" rowspan="1" colspan="1">MRI</td><td align="center" valign="top" rowspan="1" colspan="1">Chest CT/PCR/history of exposure/symptomatology</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dhamoon, et&#160;al. [<xref rid="rmv70069-bib-0027" ref-type="bibr">27</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2021</td><td align="center" valign="top" rowspan="1" colspan="1">USA</td><td align="center" valign="top" rowspan="1" colspan="1">Retrospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">5469</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">0.0029</td><td align="center" valign="top" rowspan="1" colspan="1">0.0016</td><td align="center" valign="top" rowspan="1" colspan="1">0.0047</td><td align="center" valign="top" rowspan="1" colspan="1">General wards</td><td align="center" valign="top" rowspan="1" colspan="1">Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">PCR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dimitriadis et&#160;al. [<xref rid="rmv70069-bib-0012" ref-type="bibr">12</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2022</td><td align="center" valign="top" rowspan="1" colspan="1">Germany</td><td align="center" valign="top" rowspan="1" colspan="1">Prospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">2681</td><td align="center" valign="top" rowspan="1" colspan="1">49</td><td align="center" valign="top" rowspan="1" colspan="1">0.0180</td><td align="center" valign="top" rowspan="1" colspan="1">0.0135</td><td align="center" valign="top" rowspan="1" colspan="1">0.0240</td><td align="center" valign="top" rowspan="1" colspan="1">ICU</td><td align="center" valign="top" rowspan="1" colspan="1">CT/MRI</td><td align="center" valign="top" rowspan="1" colspan="1">PCR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ippolito et&#160;al. [<xref rid="rmv70069-bib-0013" ref-type="bibr">13</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2022</td><td align="center" valign="top" rowspan="1" colspan="1">Germany</td><td align="center" valign="top" rowspan="1" colspan="1">Retrospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">440</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">0.0204</td><td align="center" valign="top" rowspan="1" colspan="1">0.0093</td><td align="center" valign="top" rowspan="1" colspan="1">0.0384</td><td align="center" valign="top" rowspan="1" colspan="1">ICU</td><td align="center" valign="top" rowspan="1" colspan="1">CT</td><td align="center" valign="top" rowspan="1" colspan="1">PCR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Kvernland et&#160;al. [<xref rid="rmv70069-bib-0014" ref-type="bibr">14</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2020</td><td align="center" valign="top" rowspan="1" colspan="1">USA</td><td align="center" valign="top" rowspan="1" colspan="1">Retrospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">4071</td><td align="center" valign="top" rowspan="1" colspan="1">34</td><td align="center" valign="top" rowspan="1" colspan="1">0.0083</td><td align="center" valign="top" rowspan="1" colspan="1">0.0057</td><td align="center" valign="top" rowspan="1" colspan="1">0.0116</td><td align="center" valign="top" rowspan="1" colspan="1">ICU</td><td align="center" valign="top" rowspan="1" colspan="1">MRI</td><td align="center" valign="top" rowspan="1" colspan="1">RT&#8208;PCR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Leasure et&#160;al. [<xref rid="rmv70069-bib-0028" ref-type="bibr">28</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2021</td><td align="center" valign="top" rowspan="1" colspan="1">USA</td><td align="center" valign="top" rowspan="1" colspan="1">Retrospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">21,483</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">0.0022</td><td align="center" valign="top" rowspan="1" colspan="1">0.0016</td><td align="center" valign="top" rowspan="1" colspan="1">0.0029</td><td align="center" valign="top" rowspan="1" colspan="1">General wards</td><td align="center" valign="top" rowspan="1" colspan="1">Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Martio et&#160;al. [<xref rid="rmv70069-bib-0015" ref-type="bibr">15</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2023</td><td align="center" valign="top" rowspan="1" colspan="1">Chain</td><td align="center" valign="top" rowspan="1" colspan="1">Retrospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">1675</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">0.0113</td><td align="center" valign="top" rowspan="1" colspan="1">0.0068</td><td align="center" valign="top" rowspan="1" colspan="1">0.0176</td><td align="center" valign="top" rowspan="1" colspan="1">ICU</td><td align="center" valign="top" rowspan="1" colspan="1">CT</td><td align="center" valign="top" rowspan="1" colspan="1">PCR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Merkler et&#160;al. [<xref rid="rmv70069-bib-0029" ref-type="bibr">29</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2022</td><td align="center" valign="top" rowspan="1" colspan="1">USA</td><td align="center" valign="top" rowspan="1" colspan="1">Retrospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">21,420</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">0.0022</td><td align="center" valign="top" rowspan="1" colspan="1">0.0016</td><td align="center" valign="top" rowspan="1" colspan="1">0.0029</td><td align="center" valign="top" rowspan="1" colspan="1">General wards</td><td align="center" valign="top" rowspan="1" colspan="1">CT/MRI</td><td align="center" valign="top" rowspan="1" colspan="1">PCR/IgM</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pavlov et&#160;al. [<xref rid="rmv70069-bib-0030" ref-type="bibr">30</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2021</td><td align="center" valign="top" rowspan="1" colspan="1">Russia</td><td align="center" valign="top" rowspan="1" colspan="1">Retrospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">1200</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">0.0025</td><td align="center" valign="top" rowspan="1" colspan="1">0.0005</td><td align="center" valign="top" rowspan="1" colspan="1">0.0072</td><td align="center" valign="top" rowspan="1" colspan="1">General wards</td><td align="center" valign="top" rowspan="1" colspan="1">CT</td><td align="center" valign="top" rowspan="1" colspan="1">RT&#8208;PCR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Qureshi et&#160;al. [<xref rid="rmv70069-bib-0031" ref-type="bibr">31</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2020</td><td align="center" valign="top" rowspan="1" colspan="1">USA</td><td align="center" valign="top" rowspan="1" colspan="1">Retrospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">85,645</td><td align="center" valign="top" rowspan="1" colspan="1">154</td><td align="center" valign="top" rowspan="1" colspan="1">0.0017</td><td align="center" valign="top" rowspan="1" colspan="1">0.0015</td><td align="center" valign="top" rowspan="1" colspan="1">0.0021</td><td align="center" valign="top" rowspan="1" colspan="1">General wards</td><td align="center" valign="top" rowspan="1" colspan="1">Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">PCR</td></tr></tbody></table></table-wrap></sec><sec id="rmv70069-sec-0100"><label>3.3</label><title>Meta&#8208;Analysis</title><p>A random&#8208;effects model was employed to calculate the pooled risk of cerebral haemorrhage. The overall risk of cerebral haemorrhage was determined to be five cases per 1000 COVID&#8208;19 patients [0.005 (95% CI: 0.002&#8211;0.009), <italic toggle="yes">p</italic> &lt;&#160;0.001]. Significant heterogeneity was observed among the included studies (Q&#8208;value: 87.95, df&#160;=&#160;10, <italic toggle="yes">z</italic>&#8208;value&#160;=&#160;3.31, I<sup>2</sup>&#160;=&#160;99.49%, <italic toggle="yes">p</italic>&#8208;value&#160;&lt;&#160;0.001). However, a subgroup analysis was conducted to explore the research in greater detail based on the year of publication, sampling wards in a hospital, and study design (Figure&#160;<xref rid="rmv70069-fig-0002" ref-type="fig">2</xref>).</p><fig position="float" fig-type="FIGURE" id="rmv70069-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Forest plot of the pooled risk of cerebral haemorrhage in SARS&#8208;CoV&#8208;2 patients. CI, confidence interval.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="RMV-35-e70069-g003.jpg"/></fig></sec><sec id="rmv70069-sec-0110"><label>3.4</label><title>Subgroup Analysis</title><p>Subgroup analyses were conducted based on the year of publication (2020, 2021, 2022, and 2023), sampling wards in a hospital (general wards and ICU), and study design (retrospective and prospective cohort) for further investigation. Considering the significant subgroups of the included studies, articles published in 2022 and 2023 indicated a markedly higher risk of cerebral haemorrhage compared to previous years. COVID&#8208;19 patients admitted to the ICU faced an elevated risk of cerebral haemorrhage compared to those admitted to general wards (13 vs. 2 per 10,000 patients). The findings from the subgroup analysis are presented in Table&#160;<xref rid="rmv70069-tbl-0002" ref-type="table">2</xref> and Figures&#160;<xref rid="rmv70069-fig-0003" ref-type="fig">3</xref> and <xref rid="rmv70069-fig-0004" ref-type="fig">4</xref>.</p><table-wrap position="float" id="rmv70069-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Subgroup analysis assessing the role of various variables in the risk of cerebral haemorrhage among patients with SARS&#8208;CoV&#8208;2.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr><th rowspan="2" style="border-bottom:solid 1px #000000" align="left" valign="bottom" colspan="1">Subgroup</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">Number of studies</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">Risk (95% CI)</th><th rowspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" colspan="1">
<italic toggle="yes">p</italic>&#8208;value</th><th style="border-bottom:solid 1px #000000" colspan="2" align="center" valign="bottom" rowspan="1">Test of heterogeneity</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">I<sup>2</sup>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Overall results</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">0.005 (0.002, 0.009)</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">99.49</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#160;0.001</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Sampling wards in a hospital</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">General wards</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">0.002 (0.002, 0.002)</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">24.40</td><td align="center" valign="top" rowspan="1" colspan="1">0.261</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">ICU</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">0.013 (0.008, 0.018)</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">75.70</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Year of publication</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2020</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">0.004 (0.000, 0.008)</td><td align="center" valign="top" rowspan="1" colspan="1">0.058</td><td align="center" valign="top" rowspan="1" colspan="1">91.62</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#160;0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2021</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">0.002 (0.002, 0.002)</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">35.12</td><td align="center" valign="top" rowspan="1" colspan="1">0.184</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2022</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">0.013 (0.001, 0.024)</td><td align="center" valign="top" rowspan="1" colspan="1">0.036</td><td align="center" valign="top" rowspan="1" colspan="1">94.09</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#160;0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2023</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.011 (0.006, 0.016)</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8212;</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Study design</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Prospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0.010 (&#8722;0.006, 0.025)</td><td align="center" valign="top" rowspan="1" colspan="1">0.221</td><td align="center" valign="top" rowspan="1" colspan="1">97.38</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#160;0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Retrospective cohort</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">0.004 (0.002, 0.006)</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">98.29</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#160;0.001</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Diagnosis method</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">0.002 (0.002, 0.002)</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">35.12</td><td align="center" valign="top" rowspan="1" colspan="1">0.184</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CT</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">0.010 (0.002, 0.002)</td><td align="center" valign="top" rowspan="1" colspan="1">0.039</td><td align="center" valign="top" rowspan="1" colspan="1">87.78</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MRI</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0.005 (&#8722;0.002, 0.011)</td><td align="center" valign="top" rowspan="1" colspan="1">0.161</td><td align="center" valign="top" rowspan="1" colspan="1">95.46</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#160;0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CT/MRI</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0.010 (&#8722;0.006, 0.009)</td><td align="center" valign="top" rowspan="1" colspan="1">0.210</td><td align="center" valign="top" rowspan="1" colspan="1">97.29</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#160;0.001</td></tr></tbody></table></table-wrap><fig position="float" fig-type="FIGURE" id="rmv70069-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Forest plot illustrating the pooled risk of cerebral haemorrhage in patients with SARS&#8208;CoV&#8208;2, categorised by year of publication. CI, confidence interval.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="RMV-35-e70069-g002.jpg"/></fig><fig position="float" fig-type="FIGURE" id="rmv70069-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Forest plot illustrating the pooled risk of cerebral haemorrhage in patients with SARS&#8208;CoV&#8208;2, categorised by sampling wards in a hospital. CI, confidence interval.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="RMV-35-e70069-g001.jpg"/></fig></sec><sec id="rmv70069-sec-0120"><label>3.5</label><title>Meta&#8208;Regression</title><p>Meta&#8208;regression analysis revealed a statistically significant association between the risk of cerebral haemorrhage and the sampling wards in a hospital [0.0089 (95% CI: 0.0067&#8211;0.0112), <italic toggle="yes">p</italic>&#160;&lt;&#160;0.001], as well as the year of publication [0.0004 (95% CI: 0.0003&#8211;0.0008), <italic toggle="yes">p</italic>&#160;=&#160;0.048]. No statistically significant difference was observed in the risk of cerebral haemorrhage based on the diagnostic method used for cerebral haemorrhage. Following the meta&#8208;regression analysis that included significant variables, the heterogeneity among the studies was generally reduced (Q&#8208;value: 12.36, df&#160;=&#160;5, I<sup>2</sup>&#160;=&#160;11.66%, <italic toggle="yes">p</italic>&#8208;value&#160;=&#160;0.030). Detailed results of the meta&#8208;regression are presented in Table&#160;<xref rid="rmv70069-tbl-0003" ref-type="table">3</xref>.</p><table-wrap position="float" id="rmv70069-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>A random meta&#8208;regression analysis of covariates associated with the risk of cerebral haemorrhage in patients infected with SARS&#8208;CoV&#8208;2.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th style="border-bottom:solid 1px #000000" colspan="2" align="left" valign="bottom" rowspan="1">Moderators</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">&#946;</italic>&#8208;coefficient</th><th align="center" valign="bottom" rowspan="1" colspan="1">SE</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Z</italic> value</th><th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">2&#8208;sided <italic toggle="yes">p</italic> value</th></tr></thead><tbody valign="top"><tr><td colspan="2" align="left" valign="top" rowspan="1">Year of publication</td><td align="center" valign="top" rowspan="1" colspan="1">0.0004</td><td align="center" valign="top" rowspan="1" colspan="1">0.0002</td><td align="center" valign="top" rowspan="1" colspan="1">1.98</td><td align="center" valign="top" rowspan="1" colspan="1">0.0003 to 0.0008</td><td align="center" valign="top" rowspan="1" colspan="1">0.048</td></tr><tr><td colspan="2" align="left" valign="top" rowspan="1">Sampling wards in a hospital</td><td align="center" valign="top" rowspan="1" colspan="1">0.0089</td><td align="center" valign="top" rowspan="1" colspan="1">0.0011</td><td align="center" valign="top" rowspan="1" colspan="1">7.76</td><td align="center" valign="top" rowspan="1" colspan="1">0.0067 to 0.0112</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#160;0.001</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">Diagnosis method</td><td align="center" valign="top" rowspan="1" colspan="1">Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">Reference</td><td align="center" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">CT</td><td align="center" valign="top" rowspan="1" colspan="1">0.0004</td><td align="center" valign="top" rowspan="1" colspan="1">0.0012</td><td align="center" valign="top" rowspan="1" colspan="1">0.34</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.0021 to 0.0029</td><td align="center" valign="top" rowspan="1" colspan="1">0.734</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">MRI</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.0002</td><td align="center" valign="top" rowspan="1" colspan="1">0.0003</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.90</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.0009 to 0.0003</td><td align="center" valign="top" rowspan="1" colspan="1">0.366</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">CT/MRI</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.0002</td><td align="center" valign="top" rowspan="1" colspan="1">0.0004</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.45</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.0012 to 0.0007</td><td align="center" valign="top" rowspan="1" colspan="1">0.653</td></tr></tbody></table><table-wrap-foot id="rmv70069-ntgp-0001"><fn id="rmv70069-note-0002"><p>Abbreviation: SE, standard error.</p></fn></table-wrap-foot></table-wrap></sec><sec id="rmv70069-sec-0130"><label>3.6</label><title>Publication Bias</title><p>Publication bias in the meta&#8208;analysis was not detected using either Begg's test (<italic toggle="yes">p</italic>&#160;=&#160;0.076) or Egger's test (<italic toggle="yes">p</italic>&#160;=&#160;0.155). Significant heterogeneity was observed in the meta&#8208;analysis (Q<sub>(10)</sub>&#160;=&#160;87.95, <italic toggle="yes">p</italic>&#160;&lt;&#160;0.001). Meta&#8208;regression analyses were conducted.</p></sec></sec><sec id="rmv70069-sec-0140"><label>4</label><title>Discussion</title><p>A total of 197,060 patients with COVID&#8208;19 were included in this systematic review and meta&#8208;analysis, which comprised 11 articles that directly assessed the risk of cerebral haemorrhage. All included studies employed a cohort design and were published between 2020 and 2023. The results indicated that the risk of cerebral haemorrhage in patients with COVID&#8208;19 was elevated, and this risk was found to be statistically significant. The year of publication and the sampling wards in a hospital were identified as variables affecting the risk of cerebral haemorrhage.</p><p>The reported risk of cerebral haemorrhage in this study was five cases per 10,000 COVID&#8208;19 patients, with a range of 15&#8211;204 cases. There was variability in the risk of cerebral haemorrhage among individuals with COVID&#8208;19 across the included studies. This variability may reflect differences in the patient populations studied; the highest risks were reported in cohorts of critically ill patients and in studies examining the neurological complications of COVID&#8208;19. Additionally, it may also reflect differences in healthcare system organisation and the intensity of neurological screening. Overall, we observed the highest stroke risk in patients in the intensive care unit (ICU) [<xref rid="rmv70069-bib-0012" ref-type="bibr">12</xref>, <xref rid="rmv70069-bib-0013" ref-type="bibr">13</xref>, <xref rid="rmv70069-bib-0014" ref-type="bibr">14</xref>, <xref rid="rmv70069-bib-0015" ref-type="bibr">15</xref>]. While our analysis identified a higher risk of ICH in ICU patients, this finding aligns with the expected clinical severity and comorbid burden in such settings. It underscores the need for heightened vigilance rather than indicating a novel association.</p><p>These cerebral hemorrhages were more frequently classified as cryptogenic compared to both contemporary and historical controls for cerebral haemorrhage [<xref rid="rmv70069-bib-0016" ref-type="bibr">16</xref>]. The findings from the comparison between cerebral hemorrhages associated with COVID&#8208;19 and those without may suggest that certain mechanisms directly related to COVID&#8208;19 play a role in the occurrence of cerebral haemorrhage, thereby elucidating the distinctive profile of cerebral haemorrhage in infected patients [<xref rid="rmv70069-bib-0017" ref-type="bibr">17</xref>, <xref rid="rmv70069-bib-0018" ref-type="bibr">18</xref>]. Severe cases of COVID&#8208;19 can result in pathology across multiple organ systems through various mechanisms. One mechanism by which multiple organ systems become damaged is related to direct viral invasion, as the ACE&#8208;2 receptor is highly expressed in numerous organs, and viral replication can lead to cell death [<xref rid="rmv70069-bib-0019" ref-type="bibr">19</xref>, <xref rid="rmv70069-bib-0020" ref-type="bibr">20</xref>]. A second mechanism is involves systemic inflammatory response seen observed severe cases of COVID&#8208;19, which is by cytokine dysregulation, dysregulation and can lead shock. Increased vascular permeability and extravasation of both neutrophils and the in combination with viral binding to endothelial combined also lead to vasculopathy and vasculitis [<xref rid="rmv70069-bib-0020" ref-type="bibr">20</xref>, <xref rid="rmv70069-bib-0021" ref-type="bibr">21</xref>]. A final result in which Covid&#8208;19 can cause damage Finally, COVID&#8208;19 associated coagulopathy (CAC). CAC is characterised by initial in COVID&#8208;19 associated and it leads to both vascular thrombosis and parenchymal haemorrhage [<xref rid="rmv70069-bib-0022" ref-type="bibr">22</xref>, <xref rid="rmv70069-bib-0023" ref-type="bibr">23</xref>].</p><p>An important question is whether cerebral hemorrhages occurring in individuals with COVID&#8208;19 are causally related to the virus or merely represent an incidental association due to the widespread prevalence of COVID&#8208;19 in the community. The occurrence of cerebral hemorrhages in patients with COVID&#8208;19 does not provide direct evidence of a causal link between the two conditions. As with all observational studies, residual confounding may be a contributing factor, as a significant proportion of patients hospitalised with both COVID&#8208;19 and cerebral hemorrhages exhibit various vascular risk factors. Additionally, certain COVID&#8208;19&#8208;related factors, such as poorly controlled vascular risk factors and mental stress, may also contribute to the risk of cerebral hemorrhages. However, several lines of evidence suggest that COVID&#8208;19 may act as a trigger or risk factor for cerebral haemorrhage in at least some cases. First, SARS&#8208;CoV&#8208;2 infection appears to be more likely to cause thrombotic vascular events, including cerebral haemorrhage, compared to other coronaviruses and seasonal infectious diseases, with a 7.6&#8208;fold increase in the odds of cerebral haemorrhage associated with COVID&#8208;19 compared to influenza [<xref rid="rmv70069-bib-0024" ref-type="bibr">24</xref>]. Second, the characteristic pattern of cerebral haemorrhage in individuals with COVID&#8208;19&#8212;marked by a more proportion of large artery occlusions, infarctions involving multiple territories, and an increased risk of cryptogenic aetiology&#8212;suggests a causal relationship in at least a subset of patients [<xref rid="rmv70069-bib-0016" ref-type="bibr">16</xref>].</p><p>To explore the sources of heterogeneity among the selected studies, subgroup analyses were conducted. Initially, we assessed the risk of cerebral haemorrhage across subgroups based on the year of publication, types of hospital wards, and study design. The results indicated that the highest risk of cerebral haemorrhage was found in articles published in 2022 [0.013 (95% CI: 0.001&#8211;0.024), <italic toggle="yes">p</italic>&#160;=&#160;0.036], particularly among COVID&#8208;19 patients admitted to the ICU [0.013 (95% CI: 0.008&#8211;0.018), <italic toggle="yes">p</italic>&#160;&lt;&#160;0.001]. Furthermore, the analysis of the sample groups revealed that the risk of cerebral haemorrhage was higher in the prospective cohort compared to the retrospective cohort study. Meta&#8208;regression analysis revealed a significant association between an increased risk of cerebral haemorrhage and both study type and sampling wards within a hospital. The risk of cerebral haemorrhage in COVID&#8208;19 patients increased by 4 per 10,000 per year [0.0004 (95% CI: 0.0003&#8211;0.0008), <italic toggle="yes">p</italic>&#160;=&#160;0.048]. Furthermore, the risk of cerebral haemorrhage in COVID&#8208;19 patients admitted to the ICU was 89 per 10,000 higher than that of patients in general hospital wards [0.0089 (95% CI: 0.0067&#8211;0.0112), <italic toggle="yes">p</italic>&#160;&lt;&#160;0.001]. The included studies varied in their diagnostic criteria for ICH, with some using confirmed through neuroimaging and others relying on International Classification of Diseases (ICD) codes. This variability introduces a significant degree of heterogeneity (I<sup>2</sup>), which may affect the generalisability of our findings. We addressed this issue through subgroup analyses and found no statistically significant difference in the risk of cerebral haemorrhage among patients with COVID&#8208;19, regardless of the diagnostic method used. However, because this study relied on primary observational studies&#8212;conducted on diverse populations and susceptible to bias&#8212;heterogeneity in such systematic reviews and meta&#8208;analyses is inevitable.</p></sec><sec id="rmv70069-sec-0150"><label>5</label><title>Conclusion</title><p>Despite notable heterogeneity across studies, our meta&#8208;analysis using a random&#8208;effects model suggests that COVID&#8208;19 is associated with an increased risk of cerebral haemorrhage. This risk is particularly elevated in ICU settings, reflecting the severity of illness in these patients. The variability in diagnostic methods and differing study designs highlight the need for cautious interpretation. While no novel mechanisms are implied, these findings underscore the importance of vigilant monitoring for ICH in critically ill COVID&#8208;19 patients. Future research should aim to standardise diagnostic criteria and investigate potential mechanistic links.</p></sec><sec id="rmv70069-sec-0160"><title>Author Contributions</title><p>Y.W. and C.Z. wrote the manuscript. Y.Z. and Z.Z. designed the study. Y.W. and C.Z. analysed the data, generated charts, and wrote the manuscript. C.Z. reviewed the manuscript. Y.W. helped to collect data and assemble references. Y.Z. and Z.Z. supervised the study. All authors contributed to the article and approved the submitted version.</p></sec><sec id="rmv70069-sec-0170"><title>Ethics Statement</title><p>The authors have nothing to report.</p></sec><sec id="rmv70069-sec-0180"><title>Consent</title><p>The authors have nothing to report.</p></sec><sec sec-type="COI-statement" id="rmv70069-sec-0190"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec></body><back><sec sec-type="data-availability" id="rmv70069-sec-0210"><title>Data Availability Statement</title><p>The original contributions presented in the study are included in the article; further enquiries can be directed to the corresponding author.</p></sec><ref-list content-type="cited-references" id="rmv70069-bibl-0001"><title>References</title><ref id="rmv70069-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="rmv70069-cit-0001"><string-name name-style="western"><given-names>M. J.</given-names><surname>Zahid</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Baig</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Galvez&#8208;Jimenez</surname></string-name>, and <string-name name-style="western"><given-names>N.</given-names><surname>Martinez</surname></string-name>, &#8220;<article-title>Hemorrhagic Stroke in Setting of Severe COVID&#8208;19 Infection Requiring Extracorporeal Membrane Oxygenation (ECMO)</article-title>,&#8221; <source>Journal of Stroke and Cerebrovascular Diseases</source><volume>29</volume>, no. <issue>9</issue> (<year>2020</year>): <elocation-id>105016</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2020.105016</pub-id>.<pub-id pub-id-type="pmid">32807431</pub-id><pub-id pub-id-type="pmcid">PMC7275181</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="rmv70069-cit-0002"><string-name name-style="western"><given-names>F.</given-names><surname>Zhou</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Yu</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Du</surname></string-name>, et&#160;al., &#8220;<article-title>Clinical Course and Risk Factors for Mortality of Adult Inpatients With COVID&#8208;19 in Wuhan, China: A Retrospective Cohort Study</article-title>,&#8221; <source>Lancet</source><volume>395</volume>, no. <issue>10229</issue> (<year>2020</year>): <fpage>1054</fpage>&#8211;<lpage>1062</lpage>, <pub-id pub-id-type="doi">10.1016/s0140-6736(20)30566-3</pub-id>.<pub-id pub-id-type="pmid">32171076</pub-id><pub-id pub-id-type="pmcid">PMC7270627</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="rmv70069-cit-0003"><string-name name-style="western"><given-names>B.</given-names><surname>Li</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Yang</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Zhao</surname></string-name>, et&#160;al., &#8220;<article-title>Prevalence and Impact of Cardiovascular Metabolic Diseases on COVID&#8208;19 in China</article-title>,&#8221; <source>Clinical Research in Cardiology</source><volume>109</volume>, no. <issue>5</issue> (<year>2020</year>): <fpage>531</fpage>&#8211;<lpage>538</lpage>, <pub-id pub-id-type="doi">10.1007/s00392-020-01626-9</pub-id>.<pub-id pub-id-type="pmid">32161990</pub-id><pub-id pub-id-type="pmcid">PMC7087935</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="rmv70069-cit-0004"><string-name name-style="western"><given-names>S.</given-names><surname>Naicker</surname></string-name>, <string-name name-style="western"><given-names>C. W.</given-names><surname>Yang</surname></string-name>, <string-name name-style="western"><given-names>S. J.</given-names><surname>Hwang</surname></string-name>, <string-name name-style="western"><given-names>B. C.</given-names><surname>Liu</surname></string-name>, <string-name name-style="western"><given-names>J. H.</given-names><surname>Chen</surname></string-name>, and <string-name name-style="western"><given-names>V.</given-names><surname>Jha</surname></string-name>, &#8220;<article-title>The Novel Coronavirus 2019 Epidemic and Kidneys</article-title>,&#8221; <source>Kidney International</source><volume>97</volume>, no. <issue>5</issue> (<year>2020</year>): <fpage>824</fpage>&#8211;<lpage>828</lpage>, <pub-id pub-id-type="doi">10.1016/j.kint.2020.03.001</pub-id>.<pub-id pub-id-type="pmid">32204907</pub-id><pub-id pub-id-type="pmcid">PMC7133222</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="rmv70069-cit-0005"><string-name name-style="western"><given-names>L.</given-names><surname>Mao</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Jin</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Wang</surname></string-name>, et&#160;al., &#8220;<article-title>Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China</article-title>,&#8221; <source>JAMA Neurology</source><volume>77</volume>, no. <issue>6</issue> (<year>2020</year>): <fpage>683</fpage>&#8211;<lpage>690</lpage>, <pub-id pub-id-type="doi">10.1001/jamaneurol.2020.1127</pub-id>.<pub-id pub-id-type="pmid">32275288</pub-id><pub-id pub-id-type="pmcid">PMC7149362</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="rmv70069-cit-0006"><string-name name-style="western"><given-names>J.</given-names><surname>Cates</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Lucero&#8208;Obusan</surname></string-name>, <string-name name-style="western"><given-names>R. M.</given-names><surname>Dahl</surname></string-name>, et&#160;al., &#8220;<article-title>Risk for In&#8208;Hospital Complications Associated With COVID&#8208;19 and Influenza&#8212;Veterans Health Administration, United States, October 1, 2018&#8211;May 31, 2020</article-title>,&#8221; <source>MMWR Morbidity and mortality weekly report</source><volume>69</volume>, no. <issue>42</issue> (<year>2020</year>): <fpage>1528</fpage>&#8211;<lpage>1534</lpage>, <pub-id pub-id-type="doi">10.15585/mmwr.mm6942e3</pub-id>.<pub-id pub-id-type="pmid">33090987</pub-id><pub-id pub-id-type="pmcid">PMC7583498</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="rmv70069-cit-0007"><string-name name-style="western"><given-names>A. A. M.</given-names><surname>Ordinola</surname></string-name>, <string-name name-style="western"><given-names>S. S.</given-names><surname>Osmar</surname></string-name>, <string-name name-style="western"><given-names>V. H. R.</given-names><surname>Marussi</surname></string-name>, et&#160;al., &#8220;<article-title>Cerebral Hemorrhage During the Active Phase of SARS&#8208;CoV&#8208;2 Infection in a Patient With Amyloid Angiopathy: Case Report</article-title>,&#8221; <source>Revista Brasileira de Terapia Intensiva</source><volume>32</volume>, no. <issue>4</issue> (<year>2020</year>): <fpage>603</fpage>&#8211;<lpage>605</lpage>, <pub-id pub-id-type="doi">10.5935/0103-507x.20200098</pub-id>.<pub-id pub-id-type="pmid">33470362</pub-id><pub-id pub-id-type="pmcid">PMC7853683</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="rmv70069-cit-0008"><string-name name-style="western"><given-names>A. S.</given-names><surname>Zubair</surname></string-name>, <string-name name-style="western"><given-names>L. S.</given-names><surname>McAlpine</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Gardin</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Farhadian</surname></string-name>, <string-name name-style="western"><given-names>D. E.</given-names><surname>Kuruvilla</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Spudich</surname></string-name>, &#8220;<article-title>Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review</article-title>,&#8221; <source>JAMA Neurology</source><volume>77</volume>, no. <issue>8</issue> (<year>2020</year>): <fpage>1018</fpage>&#8211;<lpage>1027</lpage>, <pub-id pub-id-type="doi">10.1001/jamaneurol.2020.2065</pub-id>.<pub-id pub-id-type="pmid">32469387</pub-id><pub-id pub-id-type="pmcid">PMC7484225</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="rmv70069-cit-0009"><string-name name-style="western"><given-names>A.</given-names><surname>Johansson</surname></string-name>, <string-name name-style="western"><given-names>M. S.</given-names><surname>Mohamed</surname></string-name>, <string-name name-style="western"><given-names>T. C.</given-names><surname>Moulin</surname></string-name>, and <string-name name-style="western"><given-names>H. B.</given-names><surname>Schi&#246;th</surname></string-name>, &#8220;<article-title>Neurological Manifestations of COVID&#8208;19: A Comprehensive Literature Review and Discussion of Mechanisms</article-title>,&#8221; <source>Journal of Neuroimmunology</source><volume>358</volume> (<year>2021</year>): <elocation-id>577658</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.jneuroim.2021.577658</pub-id>.<pub-id pub-id-type="pmid">34304141</pub-id><pub-id pub-id-type="pmcid">PMC8272134</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="rmv70069-cit-0010"><string-name name-style="western"><given-names>J.</given-names><surname>Helms</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Kremer</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Merdji</surname></string-name>, et&#160;al., &#8220;<article-title>Neurologic Features in Severe SARS&#8208;CoV&#8208;2 Infection</article-title>,&#8221; <source>New England Journal of Medicine</source><volume>382</volume>, no. <issue>23</issue> (<year>2020</year>): <fpage>2268</fpage>&#8211;<lpage>2270</lpage>, <pub-id pub-id-type="doi">10.1056/nejmc2008597</pub-id>.<pub-id pub-id-type="pmid">32294339</pub-id><pub-id pub-id-type="pmcid">PMC7179967</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="rmv70069-cit-0011"><string-name name-style="western"><given-names>D.</given-names><surname>Moher</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Liberati</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Tetzlaff</surname></string-name>, and <string-name name-style="western"><given-names>D. G.</given-names><surname>Altman</surname></string-name>, &#8220;<article-title>Preferred Reporting Items for Systematic Reviews and Meta&#8208;Analyses: The PRISMA Statement</article-title>,&#8221; <source>BMJ</source><volume>339</volume> (<year>July 2009</year>): <elocation-id>b2535</elocation-id>, <pub-id pub-id-type="doi">10.1136/bmj.b2535</pub-id>.<pub-id pub-id-type="pmid">19622551</pub-id><pub-id pub-id-type="pmcid">PMC2714657</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="rmv70069-cit-0012"><string-name name-style="western"><given-names>K.</given-names><surname>Dimitriadis</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Meis</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Neugebauer</surname></string-name>, et&#160;al., &#8220;<article-title>Neurologic Manifestations of COVID&#8208;19 in Critically Ill Patients: Results of the Prospective Multicenter Registry PANDEMIC</article-title>,&#8221; <source>Critical Care</source><volume>26</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>217</fpage>, <pub-id pub-id-type="doi">10.1186/s13054-022-04080-3</pub-id>.<pub-id pub-id-type="pmid">35842675</pub-id><pub-id pub-id-type="pmcid">PMC9287707</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="rmv70069-cit-0013"><string-name name-style="western"><given-names>A.</given-names><surname>Ippolito</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Urban</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Ghoroghi</surname></string-name>, et&#160;al., &#8220;<article-title>Prevalence of Acute Neurological Complications and Pathological Neuroimaging Findings in Critically Ill COVID&#8208;19 Patients With and Without VV&#8208;ECMO Treatment</article-title>,&#8221; <source>Scientific Reports</source><volume>12</volume>, no. <issue>1</issue> (<year>2022</year>): <elocation-id>17423</elocation-id>, <pub-id pub-id-type="doi">10.1038/s41598-022-21475-y</pub-id>.<pub-id pub-id-type="pmid">36261436</pub-id><pub-id pub-id-type="pmcid">PMC9579632</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="rmv70069-cit-0014"><string-name name-style="western"><given-names>A.</given-names><surname>Kvernland</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Kumar</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Yaghi</surname></string-name>, et&#160;al., &#8220;<article-title>Anticoagulation Use and Hemorrhagic Stroke in SARS&#8208;CoV&#8208;2 Patients Treated at a New York Healthcare System</article-title>,&#8221; <source>Neurocritical Care</source><volume>34</volume>, no. <issue>3</issue> (<year>2021</year>): <fpage>748</fpage>&#8211;<lpage>759</lpage>, <pub-id pub-id-type="doi">10.1007/s12028-020-01077-0</pub-id>.<pub-id pub-id-type="pmid">32839867</pub-id><pub-id pub-id-type="pmcid">PMC7444897</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="rmv70069-cit-0015"><string-name name-style="western"><given-names>A. E.</given-names><surname>Martio</surname></string-name>, <string-name name-style="western"><given-names>PdM. R.</given-names><surname>Soares</surname></string-name>, <string-name name-style="western"><given-names>O. R.</given-names><surname>Karam</surname></string-name>, <string-name name-style="western"><given-names>W. L.</given-names><surname>Padua</surname></string-name>, <string-name name-style="western"><given-names>L. B.</given-names><surname>Manzato</surname></string-name>, and <string-name name-style="western"><given-names>P. M.</given-names><surname>Mesquita Filho</surname></string-name>, &#8220;<article-title>Intracranial Hemorrhage and Covid&#8208;19: A Retrospective Analysis of 1675 Hospitalized Covid&#8208;19 Brazilian Patients</article-title>,&#8221; <source>Brain Hemorrhages</source><volume>4</volume>, no. <issue>2</issue> (<year>2023</year>): <fpage>57</fpage>&#8211;<lpage>64</lpage>, <pub-id pub-id-type="doi">10.1016/j.hest.2023.01.002</pub-id>.<pub-id pub-id-type="pmid">36694614</pub-id><pub-id pub-id-type="pmcid">PMC9850839</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="rmv70069-cit-0016"><string-name name-style="western"><given-names>S.</given-names><surname>Nannoni</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>de Groot</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Bell</surname></string-name>, and <string-name name-style="western"><given-names>H. S.</given-names><surname>Markus</surname></string-name>, &#8220;<article-title>Stroke in COVID&#8208;19: A Systematic Review and Meta&#8208;Analysis</article-title>,&#8221; <source>International Journal of Stroke</source><volume>16</volume>, no. <issue>2</issue> (<year>2021</year>): <fpage>137</fpage>&#8211;<lpage>149</lpage>, <pub-id pub-id-type="doi">10.1177/1747493020972922</pub-id>.<pub-id pub-id-type="pmid">33103610</pub-id><pub-id pub-id-type="pmcid">PMC7859578</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="rmv70069-cit-0017"><string-name name-style="western"><given-names>S.</given-names><surname>Yaghi</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Ishida</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Torres</surname></string-name>, et&#160;al., &#8220;<article-title>SARS&#8208;CoV&#8208;2 and Stroke in a New York healthcare System</article-title>,&#8221; <source>Stroke</source><volume>51</volume>, no. <issue>7</issue> (<year>2020</year>): <fpage>2002</fpage>&#8211;<lpage>2011</lpage>, <pub-id pub-id-type="doi">10.1161/strokeaha.120.030335</pub-id>.<pub-id pub-id-type="pmid">32432996</pub-id><pub-id pub-id-type="pmcid">PMC7258764</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="rmv70069-cit-0018"><string-name name-style="western"><given-names>J. D.</given-names><surname>Spence</surname></string-name>, <string-name name-style="western"><given-names>G. R.</given-names><surname>de Freitas</surname></string-name>, <string-name name-style="western"><given-names>L. C.</given-names><surname>Pettigrew</surname></string-name>, et&#160;al., &#8220;<article-title>Mechanisms of Stroke in COVID&#8208;19</article-title>,&#8221; <source>Cerebrovascular Diseases</source><volume>49</volume>, no. <issue>4</issue> (<year>2020</year>): <fpage>451</fpage>&#8211;<lpage>458</lpage>, <pub-id pub-id-type="doi">10.1159/000509581</pub-id>.<pub-id pub-id-type="pmid">32690850</pub-id><pub-id pub-id-type="pmcid">PMC7445374</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="rmv70069-cit-0019"><string-name name-style="western"><given-names>C.</given-names><surname>Bryce</surname></string-name>, <string-name name-style="western"><given-names>Z.</given-names><surname>Grimes</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Pujadas</surname></string-name>, et&#160;al., &#8220;<article-title>Pathophysiology of SARS&#8208;CoV&#8208;2: The Mount Sinai COVID&#8208;19 Autopsy Experience</article-title>,&#8221; <source>Modern Pathology</source><volume>34</volume>, no. <issue>8</issue> (<year>2021</year>): <fpage>1456</fpage>&#8211;<lpage>1467</lpage>, <pub-id pub-id-type="doi">10.1038/s41379-021-00793-y</pub-id>.<pub-id pub-id-type="pmid">33795830</pub-id><pub-id pub-id-type="pmcid">PMC8015313</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="rmv70069-cit-0020"><string-name name-style="western"><given-names>K.</given-names><surname>Yuki</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Fujiogi</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Koutsogiannaki</surname></string-name>, &#8220;<article-title>COVID&#8208;19 Pathophysiology: A Review</article-title>,&#8221; <source>Clinical Immunology</source><volume>215</volume> (<year>2020</year>): <elocation-id>108427</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.clim.2020.108427</pub-id>.<pub-id pub-id-type="pmid">32325252</pub-id><pub-id pub-id-type="pmcid">PMC7169933</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="rmv70069-cit-0021"><string-name name-style="western"><given-names>R. C.</given-names><surname>Becker</surname></string-name>, &#8220;<article-title>COVID&#8208;19&#8208;associated Vasculitis and Vasculopathy</article-title>,&#8221; <source>Journal of Thrombosis and Thrombolysis</source><volume>50</volume>, no. <issue>3</issue> (<year>2020</year>): <fpage>499</fpage>&#8211;<lpage>511</lpage>, <pub-id pub-id-type="doi">10.1007/s11239-020-02230-4</pub-id>.<pub-id pub-id-type="pmid">32700024</pub-id><pub-id pub-id-type="pmcid">PMC7373848</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="rmv70069-cit-0022"><string-name name-style="western"><given-names>H.</given-names><surname>Al&#8208;Samkari</surname></string-name>, <string-name name-style="western"><given-names>R. S.</given-names><surname>Karp Leaf</surname></string-name>, <string-name name-style="western"><given-names>W. H.</given-names><surname>Dzik</surname></string-name>, et&#160;al., &#8220;<article-title>COVID&#8208;19 and Coagulation: Bleeding and Thrombotic Manifestations of SARS&#8208;CoV&#8208;2 Infection</article-title>,&#8221; <source>Blood, The Journal of the American Society of Hematology</source><volume>136</volume>, no. <issue>4</issue> (<year>2020</year>): <fpage>489</fpage>&#8211;<lpage>500</lpage>, <pub-id pub-id-type="doi">10.1182/blood.2020006520</pub-id>.<pub-id pub-id-type="pmcid">PMC7378457</pub-id><pub-id pub-id-type="pmid">32492712</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="rmv70069-cit-0023"><string-name name-style="western"><given-names>F.</given-names><surname>Peyvandi</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Artoni</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Novembrino</surname></string-name>, et&#160;al., &#8220;<article-title>Hemostatic Alterations in COVID&#8208;19</article-title>,&#8221; <source>Haematologica</source><volume>106</volume>, no. <issue>5</issue> (<year>2020</year>): <fpage>1472</fpage>&#8211;<lpage>1475</lpage>, <pub-id pub-id-type="doi">10.3324/haematol.2020.262634</pub-id>.<pub-id pub-id-type="pmcid">PMC8094101</pub-id><pub-id pub-id-type="pmid">32855280</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="rmv70069-cit-0024"><string-name name-style="western"><given-names>A. E.</given-names><surname>Merkler</surname></string-name>, <string-name name-style="western"><given-names>N. S.</given-names><surname>Parikh</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Mir</surname></string-name>, et&#160;al., &#8220;<article-title>Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID&#8208;19) vs Patients With Influenza</article-title>,&#8221; <source>JAMA Neurology</source><volume>77</volume>, no. <issue>11</issue> (<year>2020</year>): <fpage>1</fpage>&#8211;<lpage>7</lpage>, <pub-id pub-id-type="doi">10.1001/jamaneurol.2020.2730</pub-id>.<pub-id pub-id-type="pmid">32614385</pub-id><pub-id pub-id-type="pmcid">PMC7333175</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0025"><label>25</label><mixed-citation publication-type="miscellaneous" id="rmv70069-cit-0025"><string-name name-style="western"><given-names>T. T.</given-names><surname>Le</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Guti&#233;rrez&#8208;Sacrist&#225;n</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Son</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Hong</surname></string-name>, <string-name name-style="western"><given-names>A. M.</given-names><surname>South</surname></string-name>, <string-name name-style="western"><given-names>B. K.</given-names><surname>Beaulieu&#8208;Jones</surname></string-name>, <string-name name-style="western"><given-names>N. H. W.</given-names><surname>Loh</surname></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Luo</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Morris</surname></string-name>, <string-name name-style="western"><given-names>K. Y.</given-names><surname>Ngiam</surname></string-name>, <string-name name-style="western"><given-names>L. P.</given-names><surname>Patel</surname></string-name>, <string-name name-style="western"><given-names>M. J.</given-names><surname>Samayamuthu</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Schriver</surname></string-name>, <string-name name-style="western"><given-names>A. L.</given-names><surname>Tan</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Moore</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Cai</surname></string-name>, <string-name name-style="western"><given-names>G. S.</given-names><surname>Omenn</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Avillach</surname></string-name>, <string-name name-style="western"><given-names>I. S.</given-names><surname>Kohane</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Visweswaran</surname></string-name>, <string-name name-style="western"><given-names>D. L.</given-names><surname>Mowery</surname></string-name>, <string-name name-style="western"><given-names>Z.</given-names><surname>Xia</surname></string-name>, and <collab collab-type="authors">4CE Consortium</collab>
, &#8220;<article-title>Multinational Prevalence of Neurological Phenotypes in Patients Hospitalized With COVID&#8208;19</article-title>,&#8221; preprint, medRxiv (<year>2021</year>): <elocation-id>2021.01.27.21249817</elocation-id>, <pub-id pub-id-type="doi">10.1101/2021.01.27.21249817</pub-id>.<pub-id pub-id-type="pmcid">PMC8510999</pub-id><pub-id pub-id-type="pmid">34642371</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="rmv70069-cit-0026"><string-name name-style="western"><given-names>S.</given-names><surname>Shahjouei</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Naderi</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Li</surname></string-name>, et&#160;al., &#8220;<article-title>Risk of Stroke in Hospitalized SARS&#8208;CoV&#8208;2 Infected Patients: A Multinational Study</article-title>,&#8221; <source>EBioMedicine</source><volume>59</volume> (<year>2020</year>): <elocation-id>102939</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.ebiom.2020.102939</pub-id>.<pub-id pub-id-type="pmid">32818804</pub-id><pub-id pub-id-type="pmcid">PMC7429203</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="rmv70069-cit-0027"><string-name name-style="western"><given-names>M. S.</given-names><surname>Dhamoon</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Thaler</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Gururangan</surname></string-name>, et&#160;al., &#8220;<article-title>Acute Cerebrovascular Events With COVID&#8208;19 Infection</article-title>,&#8221; <source>Stroke</source><volume>52</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>48</fpage>&#8211;<lpage>56</lpage>, <pub-id pub-id-type="doi">10.1161/strokeaha.120.031668</pub-id>.<pub-id pub-id-type="pmid">33280551</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="rmv70069-cit-0028"><string-name name-style="western"><given-names>A. C.</given-names><surname>Leasure</surname></string-name>, <string-name name-style="western"><given-names>Y. M.</given-names><surname>Khan</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Iyer</surname></string-name>, et&#160;al., &#8220;<article-title>Intracerebral Hemorrhage in Patients With COVID&#8208;19: An Analysis From the COVID&#8208;19 Cardiovascular Disease Registry</article-title>,&#8221; <source>Stroke</source><volume>52</volume>, no. <issue>7</issue> (<year>2021</year>): <fpage>e321</fpage>&#8211;<lpage>e323</lpage>, <pub-id pub-id-type="doi">10.1161/strokeaha.121.034215</pub-id>.<pub-id pub-id-type="pmid">34082576</pub-id><pub-id pub-id-type="pmcid">PMC8238884</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="rmv70069-cit-0029"><string-name name-style="western"><given-names>A. E.</given-names><surname>Merkler</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Zhang</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Diaz</surname></string-name>, et&#160;al., &#8220;<article-title>Risk Stratification Models for Stroke in Patients Hospitalized With COVID&#8208;19 Infection</article-title>,&#8221; <source>Journal of Stroke and Cerebrovascular Diseases</source><volume>31</volume>, no. <issue>8</issue> (<year>2022</year>): <elocation-id>106589</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2022.106589</pub-id>.<pub-id pub-id-type="pmid">35689935</pub-id><pub-id pub-id-type="pmcid">PMC9160015</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="rmv70069-cit-0030"><string-name name-style="western"><given-names>V.</given-names><surname>Pavlov</surname></string-name>, <string-name name-style="western"><given-names>O.</given-names><surname>Beylerli</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Gareev</surname></string-name>, <string-name name-style="western"><given-names>L. F.</given-names><surname>Torres Solis</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Sol&#237;s Herrera</surname></string-name>, and <string-name name-style="western"><given-names>G.</given-names><surname>Aliev</surname></string-name>, &#8220;<article-title>COVID&#8208;19&#8208;Related Intracerebral Hemorrhage</article-title>,&#8221; <source>Frontiers in Aging Neuroscience</source><volume>12</volume> (<year>2020</year>): <elocation-id>600172</elocation-id>, <pub-id pub-id-type="doi">10.3389/fnagi.2020.600172</pub-id>.<pub-id pub-id-type="pmid">33192492</pub-id><pub-id pub-id-type="pmcid">PMC7642875</pub-id></mixed-citation></ref><ref id="rmv70069-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="rmv70069-cit-0031"><string-name name-style="western"><given-names>A. I.</given-names><surname>Qureshi</surname></string-name>, <string-name name-style="western"><given-names>W. I.</given-names><surname>Baskett</surname></string-name>, <string-name name-style="western"><given-names>W.</given-names><surname>Huang</surname></string-name>, et&#160;al., &#8220;<article-title>Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients</article-title>,&#8221; <source>Neurocritical Care</source><volume>36</volume> (<year>2022</year>): <fpage>1</fpage>&#8211;<lpage>7</lpage>, <pub-id pub-id-type="doi">10.1007/s12028-021-01297-y</pub-id>.<pub-id pub-id-type="pmid">34231186</pub-id><pub-id pub-id-type="pmcid">PMC8260011</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>